Publication related to RSI or an RSI staff member

Key characteristics of 86 agents known to cause cancer in humans.

Since the inception of the International Agency for Research on Cancer (IARC) in the early 1970s, the IARC Monographs Programme has evaluated more than 1000 agents with respect to carcinogenic hazard; of these, up to and including Volume 119 of the IARC Monographs, 120 agents met the criteria for classification as carcinogenic to humans (Group 1). Volume 100 of the IARC Monographs provided a review and update of Group 1 carcinogens. These agents were divided into six broad categories: (I) pharmaceuticals; (II) biological agents; (III) arsenic, metals, fibers, and dusts; (IV) radiation; (V) personal habits and indoor combustions; and (VI) chemical agents and related occupations. Data on biological mechanisms of action (MOA) were extracted from the Monographs to assemble a database on the basis of ten key characteristics attributed to human carcinogens. After some grouping of similar agents, the characteristic profiles were examined for 86 Group 1 agents for which mechanistic information was available in the IARC Monographs up to and including Volume 106, based upon data derived from human in vivo, human in vitro, animal in vivo, and animal in vitro studies. The most prevalent key characteristic was “is genotoxic”, followed by “alters cell proliferation, cell death, or nutrient supply” and “induces oxidative stress”. Most agents exhibited several of the ten key characteristics, with an average of four characteristics per agent, a finding consistent with the notion that cancer development in humans involves multiple pathways. Information on the key characteristics was often available from multiple sources, with many agents demonstrating concordance between human and animal sources, particularly with respect to genotoxicity. Although a detailed comparison of the characteristics of different types of agents was not attempted here, the overall characteristic profiles for pharmaceutical agents and for chemical agents and related occupations appeared similar. Further in-depth analyses of this rich database of characteristics of human carcinogens are expected to provide additional insights into the MOA of human cancer development.

Authors

  • Krewski, Daniel, Krewski D, McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Risk Sciences International, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

  • Bird, Michael, Bird M, McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

  • Al-Zoughool, Mustafa, Al-Zoughool M, McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Department of Community and Environmental Health, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

  • Birkett, Nicholas, Birkett N, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

  • Billard, Melissa, Billard M, McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

  • Milton, Brittany, Milton B, Risk Sciences International, Ottawa, Canada.

  • Rice, Jerry M, Rice JM, Department of Oncology, Georgetown University Medical Center, Georgetown University, Washington, DC, USA.

  • Grosse, Yann, Grosse Y, IARC Monographs Programme, International Agency for Research on Cancer, Lyon, France.

  • Cogliano, Vincent J, Cogliano VJ, National Center for Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC, USA.

  • Hill, Mark A, Hill MA, Department of Oncology, University of Oxford, Oxford, UK.

  • Baan, Robert A, Baan RA, International Agency for Research on Cancer (retired), Lyon, France.

  • Little, Julian, Little J, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

  • Zielinski, Jan M, Zielinski JM, McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

YEAR OF PUBLICATION: 2019
SOURCE: J Toxicol Environ Health B Crit Rev. 2019;22(7-8):244-263. doi: 10.1080/10937404.2019.1643536. Epub 2019 Oct 22.
JOURNAL TITLE ABBREVIATION: J Toxicol Environ Health B Crit Rev
JOURNAL TITLE: Journal of toxicology and environmental health. Part B, Critical reviews
ISSN: 1521-6950 (Electronic) 1093-7404 (Linking)
VOLUME: 22
ISSUE: 7-8
PAGES: 244-263
PLACE OF PUBLICATION: England
ABSTRACT:
Since the inception of the International Agency for Research on Cancer (IARC) in the early 1970s, the IARC Monographs Programme has evaluated more than 1000 agents with respect to carcinogenic hazard; of these, up to and including Volume 119 of the IARC Monographs, 120 agents met the criteria for classification as carcinogenic to humans (Group 1). Volume 100 of the IARC Monographs provided a review and update of Group 1 carcinogens. These agents were divided into six broad categories: (I) pharmaceuticals; (II) biological agents; (III) arsenic, metals, fibers, and dusts; (IV) radiation; (V) personal habits and indoor combustions; and (VI) chemical agents and related occupations. Data on biological mechanisms of action (MOA) were extracted from the Monographs to assemble a database on the basis of ten key characteristics attributed to human carcinogens. After some grouping of similar agents, the characteristic profiles were examined for 86 Group 1 agents for which mechanistic information was available in the IARC Monographs up to and including Volume 106, based upon data derived from human in vivo, human in vitro, animal in vivo, and animal in vitro studies. The most prevalent key characteristic was "is genotoxic", followed by "alters cell proliferation, cell death, or nutrient supply" and "induces oxidative stress". Most agents exhibited several of the ten key characteristics, with an average of four characteristics per agent, a finding consistent with the notion that cancer development in humans involves multiple pathways. Information on the key characteristics was often available from multiple sources, with many agents demonstrating concordance between human and animal sources, particularly with respect to genotoxicity. Although a detailed comparison of the characteristics of different types of agents was not attempted here, the overall characteristic profiles for pharmaceutical agents and for chemical agents and related occupations appeared similar. Further in-depth analyses of this rich database of characteristics of human carcinogens are expected to provide additional insights into the MOA of human cancer development.
LANGUAGE: eng
DATE OF PUBLICATION: 2019
DATE OF ELECTRONIC PUBLICATION: 20191022
DATE COMPLETED: 20200519
DATE REVISED: 20250530
MESH DATE: 2020/05/20 06:00
EDAT: 2019/10/23 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1080/10937404.2019.1643536 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski

Mustafa Al-Zoughool

Senior Toxicologist

Dr. Al-Zoughool has maintained a long-standing relationship with Risk Sciences International, both as a scientific collaborator and as a co-investigator on complex international projects. His work with RSI focuses on high-level public health risk modeling, mechanistic data analysis, and toxicological...
Read More about Mustafa Al-Zoughool